{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:36:43Z","timestamp":1769387803740,"version":"3.49.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.drugalcdep.2012.12.010","type":"journal-article","created":{"date-parts":[[2013,1,18]],"date-time":"2013-01-18T12:19:35Z","timestamp":1358511575000},"page":"112-118","source":"Crossref","is-referenced-by-count":111,"title":["Patient characteristics associated with buprenorphine\/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study"],"prefix":"10.1016","volume":"131","author":[{"given":"Jessica A.","family":"Dreifuss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret L.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Frost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garrett M.","family":"Fitzmaurice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer Sharpe","family":"Potter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Selzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Hatch-Maillette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan C.","family":"Sonne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger D.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0376-8716(98)00015-5","article-title":"Prediction of 7 months methadone maintenance treatment response by four measures of antisociality","volume":"49","author":"Alterman","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0010","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/00005053-199611000-00007","article-title":"Response to methadone maintenance and counseling in antisocial patients with and without major depression","volume":"184","author":"Alterman","year":"1996","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0015","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archpsyc.65.2.135","article-title":"An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study","volume":"65","author":"Anton","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jsat.2010.05.004","article-title":"Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: national surveys of physicians","volume":"39","author":"Arfken","year":"2010","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0376-8716(01)00122-3","article-title":"Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients","volume":"64","author":"Backmund","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0306-4603(00)00087-3","article-title":"Motivating drinking behavior change depressive symptoms may not be noxious","volume":"26","author":"Blume","year":"2001","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004714-199502000-00008","article-title":"Buprenorphine treatment of refractory depression","volume":"15","author":"Bodkin","year":"1995","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0045","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0376-8716(00)00148-4","article-title":"The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients","volume":"61","author":"Cacciola","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0306-4603(96)00005-6","article-title":"Heavy drinking, alcohol-dependent vs. nondependent methadone-maintenance clients: a follow-up study","volume":"22","author":"Chatham","year":"1997","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0740-5472(85)90043-1","article-title":"Pharmacological approaches to cocaine addiction","volume":"2","author":"Dackis","year":"1985","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0060","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jsat.2005.01.006","article-title":"Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS)","volume":"28","author":"Darke","year":"2005","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0065","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eurpsy.2004.09.002","article-title":"Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependence","volume":"19","author":"Dean","year":"2004","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0070","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1749-6632.1982.tb39483.x","article-title":"Possible antidepressive effects of opioids: action of buprenorphine","volume":"398","author":"Emrich","year":"1982","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0075","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/08897070209511496","article-title":"A staging system to predict prognosis among methadone maintenance patients, based on admission characteristics","volume":"23","author":"Favrat","year":"2002","journal-title":"Subst. Abuse"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0080","series-title":"Manual for Standard Medical Management of Opioid Dependence with Buprenorphine","author":"Fiellin","year":"1999"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0085","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0740-5472(03)00125-9","article-title":"Recovery from opioid addiction in DATOS","volume":"25","author":"Flynn","year":"2003","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0090","first-page":"126","article-title":"Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic","volume":"43","author":"Gelkopf","year":"2006","journal-title":"Isr. J. Psychiatry Relat. Sci."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0095","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neubiorev.2010.05.002","article-title":"Individual differences in prefrontal cortex function and the transition from drug use to drug dependence","volume":"35","author":"George","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2003.11.017","article-title":"Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome","volume":"75","author":"Gerra","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0105","series-title":"Pharmacies Besieged by Addicted Thieves","author":"Goodnough","year":"2011"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/JCP.0b013e318240a48e","article-title":"COMT Val158Met. BDNF Val66Met, and OPRM1 Asn40Asp and methamphetamine dependence treatment response: preliminary investigation","volume":"32","author":"Heinzerling","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/00952990802585398","article-title":"Depressive symptoms, drinking consequences, and motivation to change in first time DWI offenders","volume":"35","author":"Holt","year":"2009","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0376-8716(99)00081-2","article-title":"Prior treatment experience related to process and outcomes in DATOS","volume":"57","author":"Hser","year":"1999","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0125","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/00952999109027552","article-title":"Predictors of opiate drug abuse during a 90-day methadone detoxification","volume":"17","author":"Iguchi","year":"1991","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0376-8716(99)00088-5","article-title":"Retention and patient engagement models for different treatment modalities in DATOS","volume":"57","author":"Joe","year":"1999","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0135","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/00952999409106781","article-title":"Treatment process and relapse to opioid use during methadone maintenance","volume":"20","author":"Joe","year":"1994","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0140","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","volume":"343","author":"Johnson","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0145","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1176\/ajp.142.11.1259","article-title":"The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence","volume":"142","author":"Khantzian","year":"1985","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0150","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/10673229709030550","article-title":"The self-medication hypothesis of substance use disorders: a reconsideration and recent applications","volume":"4","author":"Khantzian","year":"1997","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0155","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/00952991003736389","article-title":"Predictors of attrition from a national sample of methadone maintenance patients","volume":"36","author":"Mancino","year":"2010","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0160","series-title":"Addictive Behaviors.","article-title":"Introduction","author":"Marlatt","year":"1997"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0165","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1037\/1064-1297.13.4.293","article-title":"Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence","volume":"13","author":"Marsch","year":"2005","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0170","series-title":"Research on the Treatment of Drug Addiction: State of the Art","first-page":"500","article-title":"Patient characteristics associated with outcome","author":"McLellan","year":"1983"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0175","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1037\/0022-006X.62.6.1141","article-title":"Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: role of treatment services","volume":"62","author":"McLellan","year":"1994","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0180","series-title":"Pain Killer: A \u201cWonder\u201d Drug's Trail of Addiction and Death","author":"Meier","year":"2003"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0185","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11606-007-0129-0","article-title":"Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients","volume":"22","author":"Moore","year":"2007","journal-title":"J. Gen. Intern. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.drugalcdep.2012.12.010_bib0190","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.drugalcdep.2006.09.008","article-title":"Developing adaptive treatment strategies in substance abuse research","volume":"88","author":"Murphy","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0195","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/10550490902925920","article-title":"Theories of addiction: methamphetamine users\u2019 explanations for continuing drug use and relapse","volume":"18","author":"Newton","year":"2009","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0200","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0002-9343(98)00194-6","article-title":"A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic","volume":"105","author":"O\u2019Connor","year":"1998","journal-title":"Am. J. Med."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0205","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0376-8716(99)00140-4","article-title":"Buprenorphine: a controlled clinical trial in the treatment of opioid dependence","volume":"60","author":"Pani","year":"2000","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0210","series-title":"Manual for Enhanced Medical Management of Opioid Dependence with Buprenorphine","author":"Pantalon","year":"1999"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0215","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drugalcdep.2009.09.013","article-title":"15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel","volume":"107","author":"Peles","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0220","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1176\/ps.50.2.219","article-title":"Therapeutic alliance and psychiatric severity as predictors of completion of treatment for opioid dependence","volume":"50","author":"Petry","year":"1999","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0225","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0376-8716(99)00058-7","article-title":"Gender differences in hostility of opioid-dependent outpatients: role in early treatment termination","volume":"58","author":"Petry","year":"2000","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0230","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1360-0443.2004.00686.x","article-title":"Depression and hostility as predictors of long-term outcomes among opiate users","volume":"99","author":"Rao","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0235","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0278-5846(91)90028-Y","article-title":"Buprenorphine responders: a diagnostic subgroup of heroin addicts?","volume":"15","author":"Resnick","year":"1991","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0240","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1046\/j.1360-0443.1996.918119711.x","article-title":"Pre-treatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome","volume":"91","author":"Saxon","year":"1996","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0245","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00005053-199801000-00006","article-title":"Prognostic factors in Buprenorphine- versus methadone-maintained patients","volume":"186","author":"Schottenfeld","year":"1998","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0250","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/10550490600625624","article-title":"Characterizing the emerging population of prescription opioid abusers","volume":"15","author":"Sigmon","year":"2006","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0255","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0376-8716(97)00099-9","article-title":"Drug abuse treatment retention and process effects on follow-up outcomes","volume":"47","author":"Simpson","year":"1997","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0260","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S146114570700836X","article-title":"Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study","volume":"11","author":"Soyka","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0265","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/09595230601036994","article-title":"Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment","volume":"26","author":"Stenbacka","year":"2007","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0270","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1300\/J126v01n03_05","article-title":"Useful predictors of outcome in methadone-treated patients: results from a controlled clinical trial with three doses of methadone","volume":"1","author":"Strain","year":"1998","journal-title":"J. Maint. Addict."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0275","series-title":"The TEDS Report: Substance Abuse Treatment Admissions Involving Abuse of Pain Relievers: 1998 and 2008.","author":"Substance Abuse and Mental Health Services Administration","year":"2010"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0280","series-title":"Results from the 2010 National Survey on Drug Use and Health: Volume I. Summary of National Findings. NSDUH Series H-41.","author":"Substance Abuse and Mental Health Services Administration","year":"2011"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0285","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1521-0391.2009.00003.x","article-title":"The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine\/naloxone for the treatment of opioid dependence","volume":"19","author":"Sullivan","year":"2010","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0290","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1360-0443.2007.02029.x","article-title":"The impact of treatment on 3 years\u2019 outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS)","volume":"103","author":"Teesson","year":"2008","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0295","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0376-8716(96)01230-6","article-title":"Retention in a low-threshold methadone maintenance program","volume":"41","author":"Torrens","year":"1996","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0300","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1521-0391.2009.00017.x","article-title":"Conducting clinical research with prescription opioid dependence: defining the population","volume":"19","author":"Weiss","year":"2010","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0305","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","article-title":"Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial","volume":"68","author":"Weiss","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0310","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cct.2010.01.003","article-title":"A multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): rationale, design, and methodology","volume":"31","author":"Weiss","year":"2010","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0315","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.addbeh.2005.05.011","article-title":"Are depressed drinking\/driving offenders more receptive to brief intervention?","volume":"31","author":"Wells-Parker","year":"2006","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0320","doi-asserted-by":"crossref","first-page":"655","DOI":"10.15288\/jsa.2002.63.655","article-title":"Enhancing the effectiveness of traditional interventions with drinking drivers by adding brief individual intervention components","volume":"63","author":"Wells-Parker","year":"2002","journal-title":"J. Stud. Alcohol"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0325","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jsat.2006.12.009","article-title":"The effect of baseline cocaine use on treatment outcomes for heroin dependence over 24 months: findings from the Australian Treatment Outcome Study","volume":"33","author":"Williamson","year":"2007","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0330","series-title":"Composite International Diagnostic Interview (CIDI): Core Version 2.1","author":"World Health Organization","year":"1997"},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0335","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2008.11.013","article-title":"Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers","volume":"101","author":"Zacny","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2012.12.010_bib0340","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00213-007-0937-2","article-title":"Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers","volume":"196","author":"Zacny","year":"2008","journal-title":"Psychopharmacol. (Berl.)"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612004863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612004863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T08:02:56Z","timestamp":1539936176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871612004863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":68,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0376871612004863"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.12.010","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}